What is Immunovant's contact information?

Immunovant's contact information: clinicaltrials@immunovant.com, info@immunovant.com, +19175803099.

What tech stack does Immunovant use?

Some of the popular technologies that Immunovant uses are: Google Analytics, Cloudflare, CDNJS, Amazon CloudFront, Amazon CloudFront CDN, Klaro.

What are Immunovant's office addresses?

Immunovant has 2 known office addresses: 320 W 37th St New York, 10018, US 324 Blackwell St Durham, North Carolina 27701, US.

What is Immunovant's estimated annual revenue?

Immunovant's revenue is $10,000,000

What is the number of ad campaigns for Immunovant?

Immunovant has no advertisements yet.

What is the number of recent news articles about Immunovant?

Immunovant has 4 news articles.

Immunovant - Pubrio Company Profile & Intent

Q: What industry does Immunovant belong to?

Immunovant is in the industry of: Research, Pharmaceuticals, Biotechnology, Healthcare, Biotechnology Research.

Immunovant

United States · Biotechnology Research

Research

Pharmaceuticals

Biotechnology

Healthcare

Biotechnology Research

Immunovant, Inc. is a clinical-stage immunology company dedicated to enabling normal lives for people with autoimmune diseases. As a trailblazer in anti-FcRn technology, the Company is developing innovative, targeted therapies to meet the complex and variable needs of people with autoimmune diseases. For additional information on the Company, please visit immunovant.com. For U.S. residents only.

Company Insights

Category and Technology

Implementation Date

Last Recorded

Analytics
- Google Analytics
  https://marketingplatform.google.com/about/analytics/
  February 3, 2023
  -
CDN
- Cloudflare
  http://www.cloudflare.com
  April 2, 2026
  -
- CDNJS
  https://cdnjs.com
  April 2, 2026
  -
- Amazon CloudFront
  http://aws.amazon.com/cloudfront/
  December 10, 2024
  -
- Amazon CloudFront CDN
  http://aws.amazon.com/cloudfront/
  February 3, 2023
  -
Cookie compliance
- Klaro
  https://heyklaro.com
  February 3, 2023
  -

Advertising
- Google AdSense
  https://www.google.com/adsense/start/
  August 2, 2025
  -
- Twitter Ads
  https://ads.twitter.com
  August 2, 2025
  -
- Amazon Advertising
  https://advertising.amazon.com
  August 2, 2025
  -
- Microsoft Advertising
  https://ads.microsoft.com
  August 2, 2025
  -
- Google Publisher Tag
  https://developers.google.com/publisher-tag/guides/get-started
  August 2, 2025
  -
- Prebid
  http://prebid.org
  August 2, 2025
  -
- DoubleClick Floodlight
  http://support.google.com/ds/answer/6029713?hl=en
  February 8, 2026
  -
- DoubleClick Campaign Manager (DCM)
  http://www.doubleclickbygoogle.com/solutions/digital-marketing/campaign-manager/
  August 2, 2025
  -
- ID5
  https://id5.io/
  August 2, 2025
  -

Get full access to view complete information

1 - 2 of 2

linkedin · Started 2/13/2026

Open ad

Stellar’s Bet: Real-World Finance, Not Hype

Coindesk

linkedin · Started 1/1/2026

Coindesk

linkedin · Started 12/25/2025

Open ad

Position Your Brand at the Center of Web3

Coindesk

Get full access to view complete information

1 - 0 of 0

docdocdoc.co.kr · has_issues_with · 6 days ago

Open news

Batoclimab Phase 3 Trial Fails

Hanolbio's licensed drug batoclimab failed to meet primary endpoint in Phase 3 trial for thyroid eye disease, though safety profile remained consistent with earlier studies.

digitaltoday.co.kr · is_developing · one week ago

Open news

Hanall Biopharma HL161 Phase 3 Results

Hanall Biopharma announced Phase 3 clinical trial results for HL161 (batoclimab) treating thyroid eye disease across 18 countries. The trial showed no statistical efficacy with 23% response rate versus 15% placebo.

docdocdoc.co.kr · launches · 2025-01-15

Open news

Immunovant highlights differentiation of FcRn inhibitor

Immunovant CEO emphasizes differentiation of FcRn inhibitor at JPM 2025, highlighting autoinjector development, dose flexibility, and market potential in autoimmune diseases.

khgames.co.kr · is_developing · 2026-03-03

Open news

Bitcoin option investors bet on downside despite price rise

Bitcoin ETF and crypto-holding firms are buying put options to hedge against potential price drops below $60,000, despite recent price increases.

khgames.co.kr · is_developing · 2026-03-03

Open news

Bitcoin's 'Death Cross' Appears: Future Trends?

Bitcoin chart shows 'death cross' pattern, historically preceding major price drops. Despite this, ETFs see $1 billion inflow and long-term investors continue accumulating.

coinreaders.com · launches · 2026-03-02

Open news

JPMorgan: Crypto Market Structure Act likely to pass mid-year

JPMorgan predicts the Crypto Market Structure Act will likely pass by mid-2026, potentially transforming the crypto market and attracting institutional investors.

Get full access to view complete information

1 - 4 of 4

Get full access to view complete information

Frequently Asked Questions Regarding Immunovant

Company Overview

2018

Founded

Biotechnology Research

Industry

United States

Location

2,636,389

Ranking

400 employees

Size

Similar Companies

Get full access to view complete information

Company Insights

Analytics

CDN

Cookie compliance

Advertising

Frequently Asked Questions Regarding Immunovant

What is Immunovant's contact information?

How many employees does Immunovant have?

What industry does Immunovant belong to?

What does Immunovant do?

What are Immunovant's official social media profiles?

What tech stack does Immunovant use?

What are Immunovant's office addresses?

What is Immunovant's estimated annual revenue?

What is Immunovant's open headcount?

What is the number of ad campaigns for Immunovant?

What is the number of recent news articles about Immunovant?

Company Overview

Similar Companies

Frequently Asked Questions Regarding Immunovant

What is Immunovant's contact information?

How many employees does Immunovant have?

What industry does Immunovant belong to?

What does Immunovant do?

What are Immunovant's official social media profiles?

What tech stack does Immunovant use?

What are Immunovant's office addresses?

What is Immunovant's estimated annual revenue?

What is Immunovant's open headcount?

What is the number of ad campaigns for Immunovant?

What is the number of recent news articles about Immunovant?